2.47 (0.11%)
As of Apr 16, 2021
Source:
MyMD is a clinical stage pharmaceutical company committed to extending healthy lifespan. MyMD is focused on developing and commercializing two therapeutic platforms based on well-defined therapeutic targets, MYMD-1 and Supera-CBD
| Country | United States |
| Headquarters | baltimore, maryland |
| Phone Number | 856-848-8698 |
| Industry | manufacturing |
| CEO | Christopher C. Chapman, M.D. |
| Website | mymd.com |